KEYNOTE-495/KeyImPaCT: Phase 2 biomarker-directed study of pembrolizumab-based therapy for non-small cell lung cancer Meeting Abstract
| Authors: | Gutierrez, M.; Hellmann, M.; Gubens, M.; Aggarwal, C.; Tan, D.; Felip, E.; Lam, W.; Chiu, J. W. Y.; Lee, J.; Yang, J.; Garon, E.; Basso, A.; Ma, H.; Fong, L.; Snyder, A.; Yuan, J.; Herbst, R. |
| Abstract Title: | KEYNOTE-495/KeyImPaCT: Phase 2 biomarker-directed study of pembrolizumab-based therapy for non-small cell lung cancer |
| Meeting Title: | 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC) |
| Keywords: | gene expression profile; pembrolizumab; tumor mutational burden |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 14 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2019 Sept 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-10-01 |
| Start Page: | S403 |
| Language: | English |
| ACCESSION: | WOS:000492162202151 |
| DOI: | 10.1016/j.jtho.2019.08.822 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1.01-107 -- Source: Wos |
